These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3902242)

  • 21. Urapidil compared with diuretics in the treatment of mild-to-moderate essential hypertensive patients: effects on glucose metabolism, insulin sensitivity, and lipid profile.
    De Lima MD; Kohlmann NE; Neves FA; Zanella MT; Ribeiro AB; Kohlmann O
    Blood Press Suppl; 1994; 4():53-6. PubMed ID: 7804514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A
    Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy of the hypertensive crisis with urapidil. Various effects on patients with or without coronary disease].
    Zähringer J; Klepzig M; Greif J; Ludwig B; Strauer B
    Fortschr Med; 1984 Jun; 102(22):624-8. PubMed ID: 6469170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of hypertension during cardiopulmonary bypass with urapidil and phentolamine.
    Göb E; Barankay A; Richter JA
    Arzneimittelforschung; 1981; 31(9):1479-81. PubMed ID: 7197959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil.
    Wacker JR; Wagner BK; Briese V; Schauf B; Heilmann L; Bartz C; Hopp H
    Eur J Obstet Gynecol Reprod Biol; 2006 Aug; 127(2):160-5. PubMed ID: 16253414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Does urapidil attenuate the hypertensive response to tracheal intubation at the time of general anesthesia?].
    Quéré JF; Ozier Y; Bringier J; Morot B; Bernard D; Pigot B; Conseiller C
    Cah Anesthesiol; 1990 Nov; 38(5):343-4. PubMed ID: 2285871
    [No Abstract]   [Full Text] [Related]  

  • 27. Hemorheology of arterial hypertension: influence of urapidil.
    Delamaire M; Bernard MD; Boisseau MR
    Blood Press Suppl; 1995; 3():58-61. PubMed ID: 8535543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-hypertensive therapy in pregnancy-induced hypertension with urapidil].
    Wacker J; Müller J; Grischke EM; Unkels R; Bastert G
    Zentralbl Gynakol; 1994; 116(5):271-3. PubMed ID: 8023622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical evaluation of urapidil, a new antihypertensive drug: preliminary findings in Japan.
    Taniguchi K; Nakamura S; Iesaka Y; Nitta M; Ito H; Kirigaya H; Takeuchi J; Fujiwara H; Iizumi T; Inada M
    Clin Ther; 1985; 7(5):559-67. PubMed ID: 4053145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention of hypertensive crises in the perioperative period. Efficacy and safety of the use of urapidil].
    Mastronardi P; Santagata T; Noseda A; Mazzarella B
    Minerva Chir; 1996 Apr; 51(4):227-33. PubMed ID: 8927272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary results on the correlation between serum level and antihypertensive effect of urapidil (Ebrantil).
    Fischer R; Haerlin R; Steinijans V; Zech K; Bruckschen EG
    Methods Find Exp Clin Pharmacol; 1981; 3 Suppl 1():89S-93S. PubMed ID: 7321663
    [No Abstract]   [Full Text] [Related]  

  • 32. [The use of urapidil to control peroperative attacks of hypertension. 5 years' experience in West Germany].
    Scherer R
    Cah Anesthesiol; 1989 Dec; 37(8):587-95. PubMed ID: 2700314
    [No Abstract]   [Full Text] [Related]  

  • 33. Urapidil in the treatment of hypertension.
    Rosendorff C
    Drugs; 1988; 35 Suppl 6():188-92. PubMed ID: 3042358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Urapidil--a new antihypertensive agent].
    Becker R
    ZFA (Stuttgart); 1982 Dec; 58(35-36):1953-5. PubMed ID: 7164559
    [No Abstract]   [Full Text] [Related]  

  • 35. Modification of cardiovascular risk factors during antihypertensive treatment: current and new approach trends. The urapidil experience.
    Leonetti G
    Blood Press Suppl; 1994; 4():49-52. PubMed ID: 7804513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prazosin hydrochloride (CP-12,299-1), an oral anti-hypertensive agent: preliminary clinical observations in ambulatory patients.
    Cohen BM
    J Clin Pharmacol J New Drugs; 1970; 10(6):408-17. PubMed ID: 4920492
    [No Abstract]   [Full Text] [Related]  

  • 37. Prazosin in hypertension: a double-blind evaluation with methyldopa and placebo.
    Mroczek WJ; Fotiu S; Davidov ME; Finnerty FA
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):769-77. PubMed ID: 4217243
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of hypertension with Guanoxan].
    Leclercq P
    Brux Med; 1965 Jun; 45(24):665-72. PubMed ID: 5319769
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of different antihypertensive drugs in the emergency department.
    Hirschl MM; Seidler D; Müllner M; Kürkciyan I; Herkner H; Bur A; Laggner AN
    J Hum Hypertens; 1996 Sep; 10 Suppl 3():S143-6. PubMed ID: 8872847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical trial of Proclival in the treatment of arterial hypertension. 50 cases].
    Warembourg H; Jaillard J
    Lille Med; 1970; 15():Suppl 5:1018+. PubMed ID: 4921127
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.